Total Results: 7183
Proposed state legislation would ban drugmakers from issuing coupons to lower patients’ copayments if a cheaper, FDA-approved medication is available.
Bloomberg reports on the company’s plans to expand its market and set up its own distribution network. In other health industry news, Walgreens’ CEO talks to analysts about plans for the merger with Rite Aid, a judge rules against Regeneron Pharmaceuticals and Sanofi on a patent dispute and traders are optimistic about biotech sector.
Federal spending for Medicare Part D catastrophic coverage spiked to $33 billion in 2015, a government report shows.
In other marketplace news, closing arguments in the Anthem-Cigna merger antitrust trial are delivered and a filing alleges that Alexion managers encouraged improper sales practices by employees.
The Vermont senator and former presidential candidate is championing the measure to curb high drug prices, which recent polls suggest is supported by more than half of Californians.
Surprise medical bill protections for consumers and new painkiller prescribing requirements for doctors are among measures signed by Gov. Jerry Brown.
Commentators analyze how the election could affect health care and policy in California.
One solution to the EpiPen controversy, some advocates say, is classifying it as preventive care so consumers wouldn’t have to pay anything for the life-saving drug. But while the suggestions seems to favor consumers, a New York Times report finds Mylan is pulling the strings.
The influx of retail chains is part of a community-based health care movement, but the trend worries some merchants and residents.
The problem, known as balance billing, happens when patients are treated by an out-of-network professional at an in-network facility. Gov. Jerry Brown is expected to sign the legislation. In other news from Sacramento, regulators could learn lessons from Colorado if recreational marijuana use becomes legal in California.